OXBOF (Oxford BioDynamics) YoY EBITDA Growth : 41.30% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Oxford BioDynamics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Oxford BioDynamics's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 41.30%.

Oxford BioDynamics's EBITDA per Share for the six months ended in Sep. 2024 was $-0.03.

Oxford BioDynamics YoY EBITDA Growth Historical Data

The historical data trend for Oxford BioDynamics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics YoY EBITDA Growth Chart

Oxford BioDynamics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

YoY EBITDA Growth

Get a 7-Day Free Trial

-55.00

-53.23

26.32

-18.57

36.14

Oxford BioDynamics Semi-Annual Data
	Sep14	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															14.58	-2.94	-12.20	28.57	41.30

Oxford BioDynamics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Oxford BioDynamics's YoY EBITDA Growth for the fiscal year that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (A: Sep. 2024 )
=	(EBITDA per Share (A: Sep. 2024 )	-	EBITDA per Share (A: Sep. 2023 ))	/	\| EBITDA per Share (A: Sep. 2023 ) \|
=	(-0.053	-	-0.083)	/	\| -0.083 \|
=	36.14 %

Oxford BioDynamics's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(-0.027	-	-0.046)	/	\| -0.046 \|
=	41.30 %

Oxford BioDynamics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (OTCPK:OXBOF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

OBD:UK LMQ:Germany

Address

John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB

Website

https://www.oxfordbiodynamics.com

Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.